Home › NDC Lookup › RxCUI directory › RxCUI 349287

Fenofibrate 160 MG Oral Tablet — RxCUI 349287

RxNorm drug concept · Semantic clinical drug
RxCUI 349287 Semantic clinical drug · SCD ● Current RxNorm concept 75 FDA products 145 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI349287
Official nameFenofibrate 160 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped75
Package NDCs mapped145
Reported Medicaid activity (SDUD)367,272 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fenofibrate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps lower triglycerides, and in some products LDL cholesterol, while raising HDL in some cases. It works alongside a healthy diet, not instead of one. Which uses apply depends...
  • It depends on the product. Tricor tablets and some capsules like Antara can be taken with or without food, while Lipofen should be taken with food. Check your label or ask me, and...
  • Common ones include abdominal pain, back pain, headache, nausea, constipation and a stuffy nose. It can also raise liver enzymes, which is why you will need blood tests.
  • Call right away for muscle pain or weakness, dark urine, yellow skin or eyes, severe belly pain, or leg swelling and chest pain. Seek emergency help for facial swelling, trouble br...
📖 Read our full Fenofibrate guide →

🕸️ Concept Web — How Fenofibrate 160 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fenofibrate 160 MG Oral Tablet RxCUI 349287

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fenofibrate 8703
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fenofibrate Oral Tablet 379818
    • Fenofibrate Oral Product 1159042
    • Fenofibrate Pill 1159043
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fenofibrate 160 MG 379822

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fenofibrate 160 MG SCDC · 379822
  • Fenofibrate Oral Tablet SCDF · 379818
  • Fenofibrate Oral Product SCDG · 1159042
  • Fenofibrate Pill SCDG · 1159043

📦 FDA Products & Package NDCs

75 products · 145 package NDCs
145 package NDCs map to RxCUI 349287 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00115-5511-01 100 TABLET in 1 BOTTLE (0115-5511-01) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5511-02 500 TABLET in 1 BOTTLE (0115-5511-02) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5511-03 1000 TABLET in 1 BOTTLE (0115-5511-03) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5511-10 90 TABLET in 1 BOTTLE (0115-5511-10) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5522-01 100 TABLET in 1 BOTTLE (0115-5522-01) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5522-02 500 TABLET in 1 BOTTLE (0115-5522-02) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5522-03 1000 TABLET in 1 BOTTLE (0115-5522-03) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00115-5522-10 90 TABLET in 1 BOTTLE (0115-5522-10) FENOFIBRATE Amneal Pharmaceuticals of New York LLC 2010-02-01
00615-8270-39 30 TABLET in 1 BLISTER PACK (0615-8270-39) fenofibrate NCS HealthCare of KY, Inc dba Vangard Labs 2019-02-04
00904-7539-04 30 BLISTER PACK in 1 CARTON (0904-7539-04) / 1 TABLET in 1... FENOFIBRATE Major Pharmaceuticals 2025-05-22
27241-0116-03 90 TABLET in 1 BOTTLE (27241-116-03) fenofibrate Ajanta Pharma USA Inc. 2018-07-20
27241-0116-05 500 TABLET in 1 BOTTLE (27241-116-05) fenofibrate Ajanta Pharma USA Inc. 2018-07-20
27241-0117-03 90 TABLET in 1 BOTTLE (27241-117-03) fenofibrate Ajanta Pharma USA Inc. 2018-07-20
27241-0117-05 500 TABLET in 1 BOTTLE (27241-117-05) fenofibrate Ajanta Pharma USA Inc. 2018-07-20
33342-0347-10 90 TABLET in 1 CONTAINER (33342-347-10) Fenofibrate Macleods Pharmaceuticals Limited 2026-01-21
33342-0347-12 10 BLISTER PACK in 1 CARTON (33342-347-12) / 10 TABLET in 1... Fenofibrate Macleods Pharmaceuticals Limited 2026-01-21
33342-0347-47 9 BLISTER PACK in 1 CARTON (33342-347-47) / 14 TABLET in 1... Fenofibrate Macleods Pharmaceuticals Limited 2026-01-21
33342-0348-10 90 TABLET in 1 CONTAINER (33342-348-10) Fenofibrate Macleods Pharmaceuticals Limited 2026-01-21
33342-0348-12 10 BLISTER PACK in 1 CARTON (33342-348-12) / 10 TABLET in 1... Fenofibrate Macleods Pharmaceuticals Limited 2026-01-21
33342-0348-15 500 TABLET in 1 CONTAINER (33342-348-15) Fenofibrate Macleods Pharmaceuticals Limited 2026-01-21
35561-0343-00 63784 TABLET, FILM COATED in 1 BOX (35561-343-00) Fenofibrate Bostal LLC 2019-06-30
35561-0343-11 90 TABLET, FILM COATED in 1 BOTTLE (35561-343-11) Fenofibrate Bostal LLC 2019-06-30
35561-0343-13 500 TABLET, FILM COATED in 1 BOTTLE (35561-343-13) Fenofibrate Bostal LLC 2019-06-30
35561-0344-00 21631 TABLET, FILM COATED in 1 BOX (35561-344-00) Fenofibrate Bostal LLC 2019-06-30
35561-0344-11 90 TABLET, FILM COATED in 1 BOTTLE (35561-344-11) Fenofibrate Bostal LLC 2019-06-30
35561-0344-13 500 TABLET, FILM COATED in 1 BOTTLE (35561-344-13) Fenofibrate Bostal LLC 2019-06-30
42291-0427-50 500 TABLET, FILM COATED in 1 BOTTLE (42291-427-50) Fenofibrate AvKARE 2023-03-08
42291-0427-90 90 TABLET, FILM COATED in 1 BOTTLE (42291-427-90) Fenofibrate AvKARE 2023-03-08
42385-0935-05 500 TABLET, FILM COATED in 1 BOTTLE (42385-935-05) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0935-11 1000 TABLET, FILM COATED in 1 BOTTLE (42385-935-11) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0935-30 30 TABLET, FILM COATED in 1 BOTTLE (42385-935-30) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0935-90 90 TABLET, FILM COATED in 1 BOTTLE (42385-935-90) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0936-05 500 TABLET, FILM COATED in 1 BOTTLE (42385-936-05) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0936-11 1000 TABLET, FILM COATED in 1 BOTTLE (42385-936-11) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0936-30 30 TABLET, FILM COATED in 1 BOTTLE (42385-936-30) FENOFIBRATE Laurus Labs Limited 2020-01-13
42385-0936-90 90 TABLET, FILM COATED in 1 BOTTLE (42385-936-90) FENOFIBRATE Laurus Labs Limited 2020-01-13
42858-0454-45 90 TABLET, FILM COATED in 1 BOTTLE (42858-454-45) Fenofibrate Rhodes Pharmaceuticals LLC 2017-06-01
42858-0660-45 90 TABLET, FILM COATED in 1 BOTTLE (42858-660-45) Fenofibrate Rhodes Pharmaceuticals LLC 2017-06-01
43598-0909-90 90 TABLET, FILM COATED in 1 BOTTLE (43598-909-90) Fenofibrate Dr. Reddy's Laboratories Inc. 2020-01-31
43598-0910-05 500 TABLET, FILM COATED in 1 BOTTLE (43598-910-05) Fenofibrate Dr. Reddy's Laboratories Inc. 2020-01-31
43598-0910-90 90 TABLET, FILM COATED in 1 BOTTLE (43598-910-90) Fenofibrate Dr. Reddy's Laboratories Inc. 2020-01-31
46708-0350-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-350-30) Fenofibrate Alembic Pharmaceuticals Limited 2020-01-23
46708-0350-71 500 TABLET, FILM COATED in 1 BOTTLE (46708-350-71) Fenofibrate Alembic Pharmaceuticals Limited 2020-01-23
46708-0350-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-350-90) Fenofibrate Alembic Pharmaceuticals Limited 2020-01-23
46708-0351-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-351-30) Fenofibrate Alembic Pharmaceuticals Limited 2020-01-23
46708-0351-71 500 TABLET, FILM COATED in 1 BOTTLE (46708-351-71) Fenofibrate Alembic Pharmaceuticals Limited 2020-01-23
46708-0351-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-351-90) Fenofibrate Alembic Pharmaceuticals Limited 2020-01-23
46708-0554-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-554-90) Fenofibrate Alembic Pharmaceuticals Limited 2019-08-01
46708-0555-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-555-90) Fenofibrate Alembic Pharmaceuticals Limited 2019-08-01
46708-0555-91 1000 TABLET, FILM COATED in 1 BOTTLE (46708-555-91) Fenofibrate Alembic Pharmaceuticals Limited 2019-08-01
Observed labelers: Bryant Ranch Prepack (22) · Alembic Pharmaceuticals Inc. (12) · A-S Medication Solutions (11) · Alembic Pharmaceuticals Limited (9) · Proficient Rx LP (9) · Amneal Pharmaceuticals of New York LLC (8) · +27 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.